Content of HLA-G+ T Cells in the Peripheral Blood from Healthy Women and Breast Cancer Patients

Verfasser / Beitragende:
[E. Ostapchuk, Yu. Perfi l'eva, Sh. Talaeva, N. Omarbaeva, N. Belyaev]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/5(2015-09-01), 649-651
Format:
Artikel (online)
ID: 605536376
LEADER caa a22 4500
001 605536376
003 CHVBK
005 20210128100852.0
007 cr unu---uuuuu
008 210128e20150901xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-3038-y  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-3038-y 
245 0 0 |a Content of HLA-G+ T Cells in the Peripheral Blood from Healthy Women and Breast Cancer Patients  |h [Elektronische Daten]  |c [E. Ostapchuk, Yu. Perfi l'eva, Sh. Talaeva, N. Omarbaeva, N. Belyaev] 
520 3 |a The number of CD3+CD56-HLA-G+ cells in the peripheral blood of breast cancer patients was shown to increase by 2 times. Our results and published data suggest that the increase in the relative content of CD3+CD56-HLA-G+ cells in the circulating blood in breast cancer contributes to tumor development due to suppression of antitumor immunity. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a regulatory T cells  |2 nationallicence 
690 7 |a HLA-G  |2 nationallicence 
690 7 |a interleukin-10  |2 nationallicence 
690 7 |a TGFβ  |2 nationallicence 
700 1 |a Ostapchuk  |D E.  |u Laboratory of Molecular Immunology and Immunobiotechnology, M. A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan  |4 aut 
700 1 |a Perfi l'eva  |D Yu  |u Laboratory of Molecular Immunology and Immunobiotechnology, M. A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan  |4 aut 
700 1 |a Talaeva  |D Sh  |u AlmatyMammology Center, Kazakhstan Research Institute of Oncology and Radiology, Almaty, Kazakhstan  |4 aut 
700 1 |a Omarbaeva  |D N.  |u AlmatyMammology Center, Kazakhstan Research Institute of Oncology and Radiology, Almaty, Kazakhstan  |4 aut 
700 1 |a Belyaev  |D N.  |u Laboratory of Molecular Immunology and Immunobiotechnology, M. A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/5(2015-09-01), 649-651  |x 0007-4888  |q 159:5<649  |1 2015  |2 159  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-3038-y  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-3038-y  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ostapchuk  |D E.  |u Laboratory of Molecular Immunology and Immunobiotechnology, M. A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Perfi l'eva  |D Yu  |u Laboratory of Molecular Immunology and Immunobiotechnology, M. A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Talaeva  |D Sh  |u AlmatyMammology Center, Kazakhstan Research Institute of Oncology and Radiology, Almaty, Kazakhstan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Omarbaeva  |D N.  |u AlmatyMammology Center, Kazakhstan Research Institute of Oncology and Radiology, Almaty, Kazakhstan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Belyaev  |D N.  |u Laboratory of Molecular Immunology and Immunobiotechnology, M. A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/5(2015-09-01), 649-651  |x 0007-4888  |q 159:5<649  |1 2015  |2 159  |o 10517